Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine
Acta Pharmaceutica Sinica B · 2023-02 · 13 (2) · 478-497
DOI: 10.1016/j.apsb.2022.09.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-02. Verfasst von Yeuan Ting Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia. Die Arbeit wurde bisher 239-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Higher Education, Malaysia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Förderung
- Ministry of Higher Education, Malaysia
Zitieren
APA
Lee, Y. T., Tan, Y. J., & Oon, C. E. (2023). Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharmaceutica Sinica B, 13(2), 478-497. https://doi.org/10.1016/j.apsb.2022.09.010
Vancouver
Lee YT, Tan YJ, Oon CE. Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharmaceutica Sinica B. 2023;13(2):478-497. doi:10.1016/j.apsb.2022.09.010
BibTeX
@article{Lee2023,
author = {Lee, Yeuan Ting and Tan, Yi Jer and Oon, Chern Ein},
title = {Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {2},
pages = {478--497},
doi = {10.1016/j.apsb.2022.09.010}
}
EUVIMED